Papers
5
Total Citations
147
H-Index
4
About
Dr. Kewei Xu is a pioneering urologic surgeon and researcher whose work has significantly advanced the field of robotic-assisted surgery. His primary research focuses on minimally invasive urologic oncology, particularly the application of robotic platforms for complex procedures like radical cystectomy and partial nephrectomy. Dr. Xu’s landmark 2012 systematic review and meta-analysis comparing robot-assisted radical cystectomy to open surgery, cited over 100 times, provided crucial early evidence supporting the safety and efficacy of the robotic approach for bladder cancer. He has also systematically evaluated robotic partial nephrectomy for large renal tumors, helping to expand the indications for nephron-sparing surgery. Demonstrating a commitment to next-generation technology, Dr. Xu led a feasibility study using the novel EDGE SP1000 single-port robotic system for nephrectomy in a porcine model, pushing the boundaries of surgical innovation. His recent work includes a meta-analysis on robotic pyeloplasty in pediatric patients, showcasing his versatility across adult and pediatric urology. With a career dedicated to evidence-based evaluation of emerging technologies, Dr. Xu’s contributions are shaping the future of minimally invasive urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5View Selection for Industrial Object Recognition2 citations · 2022